ANTIVIRAL:
CLOUDBREAK® AVCs

Cidara is developing a new generation of immunotherapeutic antivirals from its Cloudbreak platform that couple potent antivirals to a human antibody fragment. These long-acting, antiviral conjugates (AVCs) directly inhibit viral proliferation while simultaneously engaging the immune system to maximize viral clearance.

Overview

Influenza

HIV, RSV, Coronavirus
And Other Viruses

AVCs have the potential to treat and prevent other life-threatening viruses, including RSV, HIV and coronavirus. Preclinical and discovery efforts are ongoing.

Subscribe here for updates.